Your browser doesn't support javascript.
loading
Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes.
Oka, Shiro; Tanaka, Shinji; Kajiwara, Yoshiki; Saito, Shoichi; Fukunaga, Yosuke; Takamatsu, Manabu; Kawachi, Hiroshi; Hotta, Kinich; Ikematsu, Hiroaki; Kojima, Motohiro; Saito, Yutaka; Yamada, Masayoshi; Kanemitsu, Yukihide; Sekine, Shigeki; Nagata, Shinji; Yamada, Kazutaka; Kobayashi, Nozomu; Ishihara, Soichiro; Saitoh, Yusuke; Matsuda, Kenji; Togashi, Kazutomo; Komori, Koji; Ishiguro, Megumi; Kuwai, Toshio; Okuyama, Takashi; Ohuchi, Akihiro; Ohnuma, Shinobu; Sakamoto, Kazuhiro; Sugai, Tamotsu; Katsumata, Kenji; Matsushita, Hiro-O; Yamano, Hiro-O; Eda, Hirotsugu; Uraoka, Toshio; Akimoto, Naohiko; Kobayashi, Hirotoshi; Sugihara, Kenichi; Ueno, Hideki.
Affiliation
  • Oka S; Department of Gatroenterology, Hiroshima University Hospital, Hiroshima, Japan.
  • Tanaka S; Department of Gatroenterology, Hiroshima University Hospital, Hiroshima, Japan.
  • Kajiwara Y; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
  • Saito S; Department of Lower Gastrointestinal Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Fukunaga Y; Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takamatsu M; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kawachi H; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hotta K; Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ikematsu H; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kojima M; Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Saito Y; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
  • Yamada M; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
  • Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Sekine S; Pathology and Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan.
  • Nagata S; Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.
  • Yamada K; Coloproctology Center Takano Hospital, Kumamoto, Japan.
  • Kobayashi N; Department of Gastroenterology, Tochigi Cancer Center, Utsunomiya, Japan.
  • Ishihara S; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Saitoh Y; Digestive Disease Center, Asahikawa City Hospital, Hokkaido, Japan.
  • Matsuda K; Second Department of Surgery, School of Medicine, Wakayama Medical University, Wakayama, Japan.
  • Togashi K; Department of Coloproctology, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
  • Komori K; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Ishiguro M; Department of Translational Oncology, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kuwai T; Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Okuyama T; Department of Surgery, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
  • Ohuchi A; Department of Gastroenterology, School of Medicine, Kurume University, Fukuoka, Japan.
  • Ohnuma S; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sakamoto K; Department of Coloproctological Surgery, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Sugai T; Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Iwate, Japan.
  • Katsumata K; Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan.
  • Matsushita HO; Digestive Disease Center, Akita Red Cross Hospital, Akita, Japan.
  • Yamano HO; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Eda H; Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
  • Uraoka T; Department of Gastroenterology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Akimoto N; Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.
  • Kobayashi H; Department of Surgery, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Sugihara K; Tokyo Medical and Dental University, Tokyo, Japan .
  • Ueno H; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Am J Gastroenterol ; 2024 Feb 12.
Article de En | MEDLINE | ID: mdl-38345215
ABSTRACT

INTRODUCTION:

To verify the value of the pathological criteria for additional treatment in locally resected pT1 colorectal carcinoma (CRC) which have been used in the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines since 2009.

METHODS:

We enrolled 4,667 patients with pT1 CRC treated at 27 institutions between July 2009 and December 2016 (1,257 patients with local resection alone [group A], 1,512 patients with additional surgery after local resection [group B], and 1,898 patients with surgery alone [group C]). All 5 factors of the JSCCR guidelines (submucosal resection margin, tumor histologic grade, submucosal invasion depth, lymphovascular invasion, and tumor budding) for lymph node metastasis (LNM) had been diagnosed prospectively.

RESULTS:

Any of the risk factors were present in 3,751 patients. The LNM incidence was 10.4% (95% confidence interval 9.4-11.5) in group B/C patients with risk factors, whereas it was 1.8% (95% confidence interval 0.4-5.3) in those without risk factors ( P < 0.01). In group A, the incidence of recurrence was 3.6% in patients with risk factors, but it was only 0.4% in patients without risk factors ( P < 0.01). The disease-free survival rate of group A patients classified as risk positive was significantly worse than those of groups B and C patients. However, the 5-year disease-free survival rate in group A patients with no risk was 99.6%.

DISCUSSION:

Our large-scale real-world multicenter study demonstrated the validity of the JSCCR criteria for pT1 CRC after local resection, especially regarding favorable outcomes in patients with low risk of LNM.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Langue: En Journal: Am J Gastroenterol Année: 2024 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Langue: En Journal: Am J Gastroenterol Année: 2024 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique